LONDON – Oxford BioDynamics PLC (LON:), a clinical diagnostics company specializing in precision medicine, announced a retail offer to raise up to £500,000 through a new share issue. This offer is exclusive to existing eligible shareholders in the United States. Kingdom (TADAWUL 🙂 and is carried out through the Winterflood Retail Access Platform (WRAP).
The offer involves up to 100,000,000 new ordinary shares at an issue price of 0.5 pence each. The issue price represents a 44% discount to the average market closing price of 0.9 pence per ordinary share on Sunday. The funds raised will be used in a similar manner to the proceeds from a placement and simultaneous subscriptions intended to raise a minimum of £6 million.
The retail offering is part of the company’s broader fundraising strategy, which is dependent on shareholder approval at a general meeting scheduled for January 31, 2025 and the subsequent admission of the new shares to trading on the AIM market London Stock Exchange (LON:). Trading is expected to begin on February 4, 2025.
Oxford BioDynamics is reaching out to its retail shareholder base in the UK, giving them the opportunity to participate in the company’s growth. The minimum subscription per investor is set at £250, and the offer will close at 4.30pm on Thursday this week. Shareholders interested in participating can contact their brokers or wealth managers.
The newly issued shares of common stock will be fully paid and rank equal to existing shares of common stock, including the right to receive dividends and other distributions declared after the date of issuance.
Investors are reminded that an investment in the company carries risks and that capital is at stake. The value of investments can fluctuate, which could result in investors receiving less than their original investment.
This announcement is based on a press release and does not constitute an offer or solicitation in jurisdictions where such actions would violate applicable laws. The offer is not made in the United States, Australia, Canada, New Zealand, Japan, South Africa, any member state of the EEA or any jurisdiction where it would be illegal. The retail offering shares will not be registered under the US Securities Act and will not be offered in the US.
The information provided in this article is for informational purposes and is not intended to be comprehensive or complete. It is based on a press release and should be read in conjunction with the company’s full announcement to obtain a comprehensive understanding of the terms and conditions of the offer.
This article was generated with the support of AI and reviewed by an editor. For more information consult our T&C.